The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
DADA NEXUS LTD ADR USD | ADR | 23344D108 | 155 | 11,756 | SH | SOLE | 11,756 | 0 | 0 | ||
PINDUODUO INC ADR USD 0.0 | ADR | 722304102 | 528 | 9,055 | SH | SOLE | 9,055 | 0 | 0 | ||
DOXIMITY INC COMMON STOCK | COM | 26622P107 | 4,654 | 92,831 | SH | SOLE | 92,831 | 0 | 0 | ||
EPIZYME INC COMMON STOCK | COM | 29428V104 | 62 | 24,687 | SH | SOLE | 24,687 | 0 | 0 | ||
CME GROUP INC | COM | 12572Q105 | 13,708 | 60,000 | SH | SOLE | 60,000 | 0 | 0 |